Richard L Whelan
Overview
Explore the profile of Richard L Whelan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1994
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu G, Standring O, King D, Gholami S, Devoe C, Thiels C, et al.
Curr Oncol
. 2025 Feb;
32(2).
PMID: 39996904
The peritoneum is the second most common site of metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Up to half of all patients that undergo curative-intent resection eventually develop peritoneal...
2.
Waheed M, Ruel N, Whelan R, Fakih M, Fong Y, Deperalta D, et al.
Ann Surg Oncol
. 2024 Dec;
32(2):709-710.
PMID: 39627637
No abstract available.
3.
Shantha Kumara H, Hedjar Y, Mitra N, Miyagaki H, Yan X, Cekic V, et al.
J Gastrointest Oncol
. 2024 Nov;
15(5):2157-2165.
PMID: 39554587
Background: Progranulin (PGRN), also identified as Precursor cell-derived growth factor (PCDGF), is a glycoprotein that is expressed and released ubiquitously. PGRN is plays a crucial role in regulating cell proliferation,...
4.
Waheed M, Ruel N, Whelan R, Fakih M, Fong Y, Deperalta D, et al.
Ann Surg Oncol
. 2024 Sep;
31(12):7998-8007.
PMID: 39271567
Background: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a novel, minimally invasive, safe, and repeatable method to treat carcinomatosis. Evidence regarding the clinical benefit (quality of life and survival) of PIPAC...
5.
Nakamura B, Senguttuvan R, Ruel N, Frankel P, Yost S, Cole S, et al.
Front Oncol
. 2024 Aug;
14:1404936.
PMID: 39148906
Introduction: Low grade serous ovarian carcinoma (LGSOC) is a rare subtype of ovarian cancer (OC) that is challenging to treat due to its relative chemoresistance. Given that LGSOC patients often...
6.
Mitra N, Whelan R
Clin Colon Rectal Surg
. 2024 Aug;
37(5):328-339.
PMID: 39132195
Endoscopic submucosal dissection (ESD) requires skills that the vast majority of endoscopists do not possess. ESD be broken down into component skills and at least three of the necessary skill...
7.
Sullivan K, Whelan R, Deperalta D, Merchea A, Dellinger T, Raoof M
Ann Surg Oncol
. 2024 Jan;
31(4):2408-2409.
PMID: 38245647
No abstract available.
8.
Raoof M, Whelan R, Sullivan K, Ruel C, Frankel P, Cole S, et al.
Ann Surg Oncol
. 2023 Jul;
30(12):7814-7824.
PMID: 37501051
Background: Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a laparoscopic locoregional treatment for peritoneal metastases (PM) from colorectal cancer (CRC) or appendiceal cancer (AC) in patients who cannot undergo cytoreductive surgery...
9.
Shantha Kumara H, Poppy A, Gamage D, Mitra N, Yan X, Hedjar Y, et al.
J Gastrointest Oncol
. 2023 Mar;
14(1):187-197.
PMID: 36915462
Background: Urokinase-type plasminogen activator-1 (uPA) is a serine protease that converts plasminogen to plasmin after binding to uPA receptor (uPAR). Plasmin catalyzes the regeneration of basement membrane, extracellular matrix, and...
10.
Raoof M, Sullivan K, Frankel P, Fakih M, Synold T, Lim D, et al.
Pleura Peritoneum
. 2022 Dec;
7(4):169-177.
PMID: 36560966
Objectives: Peritoneal metastasis (PM) from appendiceal cancer or colorectal cancer (CRC) has significant morbidity and limited survival. Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) is a minimally invasive approach to treat PM....